David Lowrance
2021
In 2021, David Lowrance earned a total compensation of $825.9K as Chief Financial Officer & Secretary at Mast Therapeutics, a 2% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $188,613 |
|---|---|
| Option Awards | $81,584 |
| Salary | $395,000 |
| Stock Awards | $138,750 |
| Other | $22,000 |
| Total | $825,947 |
Lowrance received $395K in salary, accounting for 48% of the total pay in 2021.
Lowrance also received $188.6K in non-equity incentive plan, $81.6K in option awards, $138.8K in stock awards and $22K in other compensation.
Rankings
In 2021, David Lowrance's compensation ranked 9,390th out of 12,406 executives tracked by ExecPay. In other words, Lowrance earned more than 24.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,390 out of 12,406 | 24th |
Division Manufacturing | 4,158 out of 5,492 | 24th |
Major group Chemicals And Allied Products | 1,838 out of 2,368 | 22nd |
Industry group Drugs | 1,630 out of 2,089 | 22nd |
Industry Pharmaceutical Preparations | 1,209 out of 1,536 | 21st |
Pay ratio
| David Lowrance's Pay | $825,947 |
|---|---|
| Median Employee's Pay | $347,829 |
| Pay Ratio | 2to 1 |
In 2021, the annual total compensation of David Lowrance was $825,947.
The annual total compensation of the median employee at Mast Therapeutics was $347,829.
The ratio of David Lowrance's pay to the pay of median employee was therefore 2 to one.
Source: SEC filing on April 19, 2022.
Lowrance's colleagues
We found two more compensation records of executives who worked with David Lowrance at Mast Therapeutics in 2021.